Literature DB >> 24915553

Glucocerebrosidase deficits in sporadic Parkinson disease.

Karen E Murphy1, Glenda M Halliday1.   

Abstract

Parkinson disease (PD) is a progressive neurodegenerative movement disorder characterized pathologically by abnormal SNCA/α-synuclein protein inclusions in neurons. Impaired lysosomal autophagic degradation of cellular proteins is implicated in PD pathogenesis and progression. Heterozygous GBA mutations, encoding lysosomal GBA/glucocerebrosidase (glucosidase, β, acid), are the greatest genetic risk factor for PD, and reduced GBA and SNCA accumulation are related in PD models. Here we review our recent human brain tissue study demonstrating that GBA deficits in sporadic PD are related to the early accumulation of SNCA, and dysregulation of chaperone-mediated autophagy (CMA) pathways and lipid metabolism.

Entities:  

Keywords:  Parkinson disease; autophagy; ceramide; chaperone-mediated autophagy; glucocerebrosidase; lysosomes; α-synuclein

Mesh:

Substances:

Year:  2014        PMID: 24915553      PMCID: PMC4203563          DOI: 10.4161/auto.29074

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  23 in total

Review 1.  Drug Repurposing in Parkinson's Disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 2.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

Review 3.  Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.

Authors:  Olive Jung; Samarjit Patnaik; Juan Marugan; Ellen Sidransky; Wendy Westbroek
Journal:  Expert Rev Proteomics       Date:  2016-04-21       Impact factor: 3.940

4.  Lipidomics Prediction of Parkinson's Disease Severity: A Machine-Learning Analysis.

Authors:  Hila Avisar; Cristina Guardia-Laguarta; Estela Area-Gomez; Matthew Surface; Amanda K Chan; Roy N Alcalay; Boaz Lerner
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

5.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

6.  The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.

Authors:  Nicole K Polinski; Terina N Martinez; Sylvie Ramboz; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Lee J Pelligrino; Sean W Clark; Jacob N Marcus; Sean M Smith; Kuldip D Dave; Mark A Frasier
Journal:  Dis Model Mech       Date:  2022-05-25       Impact factor: 5.732

7.  Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.

Authors:  Céline Galvagnion; Frederik Ravnkilde Marlet; Silvia Cerri; Anthony H V Schapira; Fabio Blandini; Donato A Di Monte
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

8.  Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity.

Authors:  Seulah Choi; Donghoon Kim; Tae-In Kam; Seungpil Yun; Sangjune Kim; Hyejin Park; Heehong Hwang; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

9.  Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.

Authors:  Marcus Keatinge; Hai Bui; Aswin Menke; Yu-Chia Chen; Anna M Sokol; Qing Bai; Felix Ellett; Marc Da Costa; Derek Burke; Matthew Gegg; Lisa Trollope; Thomas Payne; Aimee McTighe; Heather Mortiboys; Sarah de Jager; Hugh Nuthall; Ming-Shang Kuo; Angeleen Fleming; Anthony H V Schapira; Stephen A Renshaw; J Robin Highley; Agnieszka Chacinska; Pertti Panula; Edward A Burton; Michael J O'Neill; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2015-09-16       Impact factor: 6.150

10.  A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.

Authors:  Wendy Westbroek; Matthew Nguyen; Marina Siebert; Taylor Lindstrom; Robert A Burnett; Elma Aflaki; Olive Jung; Rafael Tamargo; Jorge L Rodriguez-Gil; Walter Acosta; An Hendrix; Bahafta Behre; Nahid Tayebi; Hideji Fujiwara; Rohini Sidhu; Benoit Renvoise; Edward I Ginns; Amalia Dutra; Evgenia Pak; Carole Cramer; Daniel S Ory; William J Pavan; Ellen Sidransky
Journal:  Dis Model Mech       Date:  2016-05-19       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.